Status:

UNKNOWN

Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study

Lead Sponsor:

Anhui Medical University

Conditions:

Magnetic Resonance Imaging

Asymptomatic Intracranial Stenosis

Eligibility:

All Genders

18-80 years

Brief Summary

To investigate the cognitive decline after standard medical treatment without stenting in Asymptomatic Intracranial Stenosis patients and the underlying neural mechanism by fMRI.

Detailed Description

All participants underwent a medical evaluation that included routine laboratory studies before and after 1-year standard medical treatment. Upon meeting the inclusion criteria and providing informed ...

Eligibility Criteria

Inclusion

  • Patients with intracranial stenosis which was defined as stenosis of 50% or more in Intracranial segment of internal carotid artery and middle cerebral artery (MCA).
  • The degree of stenosis was measured by transcranial doppler, computed magnetic resonance angiography (MRA),tomography angiography (CTA) and digital subtraction angiography (DSA).

Exclusion

  • History of stroke,transient ischemic attack,seizures or unexplained loss of consciousness.
  • Organic brain defects on T1 or T2 images.
  • Any history or clinical signs of other severe psychiatric illnesses (like major depression,psychosis or obsessive compulsive disorder).
  • Implanted pacemaker,medication pump,vagal stimulator,deep brain stimulator. History of substance abuse within the last 6 months.

Key Trial Info

Start Date :

September 10 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04850001

Start Date

September 10 2020

End Date

December 31 2025

Last Update

April 20 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Anhui Medical University

Hefei, Anhui, China, 230032